The full-length cDNA for the rat recombinant synaptic vesicle monoamine transporter (rVMAT2) containing a COOH-terminal polyhistidine epitope was engineered into baculovirus DNA for expression in Spodoptera frugiperda (Sf9) cells. Using this recombinant baculovirus and cultured Sf9 cells, rVMAT2 has been expressed to high levels and purified to >95% homogeneity using immobilized Ni 2؉ -affinity chromatography followed by lectin (concanavalin A) chromatography. Purified transporter was photolabeled using The accumulation of amines into storage granules in neurons, into chromaffin granules in the adrenal gland, and into granules of peripheral cells such as mast cells, occurs via a monoamine transporter found in the vesicle membrane which is inhibitable by reserpine, tetrabenazine (TBZ), 1 and ketanserin (for review, see Refs. 1, 2-8). The energy for amine transport is derived from a proton gradient, generated by ATP hydrolysis, and a membrane potential (8 -10). Two protons are released from the storage vesicle in exchange for one substrate molecule transported to the inside (11, 12). The proton gradient is coupled, by an unknown mechanism, to the transport of biogenic amines into the synaptic vesicle against a steep concentration gradient. The monoamine transporter transports numerous substrates across the vesicle membrane, including dopamine, norepinephrine, epinephrine, serotonin, histamine, tyramine, meta-iodobenzylguanidine, and the neurotoxin Nmethyl-4-pyridinium (13-16).
I]TBZ-AIPP derivatized a segment of rVMAT2 between Gly-408 and Cys-431 in TMD10 and 11. These data implicate juxtaposition of TMD1 and 10/11.
The accumulation of amines into storage granules in neurons, into chromaffin granules in the adrenal gland, and into granules of peripheral cells such as mast cells, occurs via a monoamine transporter found in the vesicle membrane which is inhibitable by reserpine, tetrabenazine (TBZ), 1 and ketanserin (for review, see Refs. 1, 2-8). The energy for amine transport is derived from a proton gradient, generated by ATP hydrolysis, and a membrane potential (8 -10) . Two protons are released from the storage vesicle in exchange for one substrate molecule transported to the inside (11, 12) . The proton gradient is coupled, by an unknown mechanism, to the transport of biogenic amines into the synaptic vesicle against a steep concentration gradient. The monoamine transporter transports numerous substrates across the vesicle membrane, including dopamine, norepinephrine, epinephrine, serotonin, histamine, tyramine, meta-iodobenzylguanidine, and the neurotoxin Nmethyl-4-pyridinium (13) (14) (15) (16) .
The monoamine transporter was originally cloned from both rat PC12 cells and rat brain (17) . The rat chromaffin granule transporter (VMAT1) contains 521 amino acids, and the rat synaptic vesicle transporter (VMAT2) contains 515 amino acids. Analysis by the method of hydrophobic moments implicates 12 transmembrane helices, which is a characteristic of other known transport proteins (18, 19) . The primary sequence of both transporters predicts three potential sites of N-linked glycosylation in the large luminal loop between transmembrane helices 1 and 2. The vesicular transporters show some similarity to the bacterial multidrug resistance transporter, which is also inhibitable by reserpine (20) .
A transporter with a sequence identical to that of the rat VMAT2 was expression cloned from rat CV-1 cells (21) . The transporter activity was assayed by [ 3 H]serotonin uptake into permeabilized cells. In addition, VMAT2 has been cloned from a human brainstem cDNA library and from bovine chromaffin cell cDNA using probes derived from the rat VMAT2 (22) (23) (24) (25) . The rat VMAT2 is highly similar to these VMATs; it shares 92 and 88% identity with human and bovine VMAT2, respectively. VMAT2 from rat, human, and bovine has similar pharmacological properties (26 -29) .
A major obstacle in studying the vesicle monoamine transporters at a molecular level has been the inability to obtain large amounts of purified transporter. In an earlier study, we reported the expression and purification of a recombinant synaptic vesicle monoamine transporter (rVMAT2) using the baculovirus expression system. 2 In this paper we report the identification of the precise amino acid derivatization site of [ ries, Inc. Molecular weight standards were purchased from Sigma, and prestained molecular weight standards were from Bio-Rad. Expression and Purification of rVMAT2-rVMAT2 was expressed and purified as described earlier. 2 For large scale purification (cell culture volumes greater than 1 liter), the previous purification was modified to a batch procedure. Briefly, the Spodoptera frugiperda (Sf9) cell pellet was washed in 0.3 M sucrose, HEPES pH 7.4 buffer (S/H buffer) and solubilized in 20 mM HEPES, pH 7.4, containing 1% digitonin (40 ml of solubilization buffer/liter of original culture harvested). After centrifugation at 200,000 ϫ g for 40 min, Tris-HCl, pH 7.9, NaCl, and imidazole were added to a final concentration of 20 mM, 500 mM, and 5 mM, respectively (added as an 8 ϫ stock solution). Ni 2ϩ -NTA resin was added to the solubilized sample (500 l of resin/50 ml of extract). The resin was collected by centrifugation at 1,600 ϫ g for 5 min, resuspended in 5 mM imidazole, 500 mM NaCl, 20 mM Tris-HCl, pH 7.9, containing 0.08% digitonin, and loaded into a syringe column. The resin was washed with 20 ml of the above ice-cold buffer and eluted with 5 ml of 200 mM imidazole, 500 mM NaCl, 20 mM Tris-HCl, pH 8.1, containing 0.08% digitonin. Concanavalin A-agarose (approximately 300 l of resuspended resin) was washed with the protease mixture, I 3 (50 mM Tris-HCl, pH 7.4, 5 mM EGTA, 100 M phenylmethanesulfonyl fluoride, 100 M benzamidine, 5 g/ml soybean trypsin inhibitor, 20 g/ml leupeptin, and 5 mM MgCl 2 ) containing 0.08% digitonin (I 3 -0.08% digitonin) and added to the Ni 2ϩ column eluate. This was mixed at room temperature for 30 min. The resin was collected by centrifugation at 1,600 ϫ g for 5 min, resuspended in a small amount of I 3 -0.08% digitonin, and loaded into a small column. The resin was washed with 3 ml of ice-cold I 3 -0.08% digitonin. Elution was performed at room temperature by stopping the column flow and adding 500 l of I 3 -0.08% digitonin containing 250 mM ␣-methyl mannopyranoside (␣-mm). The resin was resuspended in the elution buffer several times over the period of 30 min, following which the eluate was collected and stored on ice. A second 500-l elution was performed in the same manner. Purified rVMAT2 was stable on ice in the cold room for more than 1 month. (Fig. 1) . To 2 mCi of Na 125 I in 10 l of 0.1 N NaOH was added 10 l of 0.1 N HCl, 50 l of NaOAc, pH 5.6, 10 l of 7-aminoketanserin I (1 mg/ml in dimethyl sulfoxide), and 10 l of chloramine T (1 mg/ml in H 2 O). The reaction was allowed to proceed for 15 min and extracted three times with 300-l aliquots of ethyl acetate. The combined extracts were concentrated to approximately 100 l, streaked onto a 10 ϫ 20-cm silica gel thin layer plate, and developed with chloroform:methanol (95:5). The product was identified by autoradiography, scraped from the plate, and the silica was extracted twice with 500-l aliquots of methanol. The yield of 7-NH 2 -8-[ 125 I]ketanserin II was 1.1 mCi (55%). All subsequent steps were performed in the dark. The methanol was removed under a stream of nitrogen gas, and immediately 100 l of ice-cold 3% H 2 SO 4 was added. After 10 min on ice, 10 l of ice-cold 1 M NaNO 2 was added. After 20 min on ice, 50 l of ice-cold 1 M NaN 3 was added. The reaction was allowed to proceed on ice for 30 min, at which time the reaction was extracted three times with 300-l aliquots of ethyl acetate. The extract was checked by thin layer chromatography developed with chloroform: methanol (95:5). The product, [
125 I]AZIK III, migrated with an R f of 0.5, while II migrated with an R f of 0.2. The conversion of II to III was quantitative, and no further purification was performed. The yield of III was 888 Ci (an overall yield of 44%). ]AZIK (1 nM) was added, and the incubation was continued in the dark for an additional 60 min on ice. The samples were photolyzed for 5 s in ice water at a distance of 10 cm from a water-jacketed 1-kilowatt high pressure mercury vapor lamp (AH-6 bulb purchased from Advanced Radiation Corporation). After photolysis, ␤-mercaptoethanol was added to a final concentration of 1%. For analysis by SDS-PAGE, loading buffer was added to a 1 ϫ concentration, and the samples were electrophoresed. For trypsin digestion, samples were either digested immediately or frozen at Ϫ20°C for storage.
For the photoaffinity labeling of large quantities of purified rVMAT2 (100 -500 g), the incubation was performed in I 3 -0.08% digitonin containing 250 mM ␣-mm as the incubation buffer.
Photoaffinity Labeling of Purified rVMAT2 with [
125 I]TBZ-AIPPPurified rVMAT2 in I 3 -0.08% digitonin and ␣-mm was incubated in 0.3 M sucrose, 10 mM HEPES, pH 7.4, containing 0.08% digitonin and 2 nM [ 125 I]TBZ-AIPP in the presence or absence of inhibitors at 30°C for 1 h. Samples were photolyzed for 5 s after which ␤-mercaptoethanol was added to a final concentration of 1%. Samples were either prepared for immediate electrophoresis by the addition of SDS-PAGE loading buffer or were frozen at Ϫ20°C until later use. For the photolabeling of large amounts of rVMAT2 (Ͼ50 g), incubation was performed in I 3 -0.08% digitonin containing 250 mM ␣-mm.
Purification of [ 125 I]AZIK-and [ 125 I]TBZ-AIPP-labeled Tryptic
Peptides-For the generation of tryptic peptides for NH 2 -terminal microsequencing, 28 l of 100 mM NaHCO 3 , pH 7.8, was added to 50 g of [ 125 I]AZIK-or [
125 I]TBZ-AIPP-labeled rVMAT2 in 250 l of I 3 -0.08% digitonin and 250 mM ␣-mm. Trypsin (10 g) was added to the sample and incubated at 37°C for 3 h. SDS-PAGE loading buffer was added to the sample, and the peptides were resolved on a 10 -18% SDS-polyacrylamide gradient gel. The following precautions were taken to prevent NH 2 -terminal blocking of the peptides by oxidation. (i) The gels were cast using the purest reagents in the preparation of the gel and buffers, including recrystallized SDS (31) . (ii) The gels were allowed to polymerize overnight at ambient temperature. (iii) During electrophoresis, 1 mM 3-mercaptopropionic acid was added to the electrophoresis buffer (32) . (iv) During staining and destaining of the polyvinylidene difluoride (PVDF) membrane, only aldehyde free acetic acid was used.
After electrophoresis of the peptides, the SDS-polyacrylamide gel was electrotransferred to a PVDF membrane according to the procedure described by Matsudaira (33) . Briefly, the gel was equilibrated in transfer buffer (10 mM CAPS, pH 11, 20% methanol) for 5 min. The PVDF membrane (Millipore, 0.45 m pore size), wetted in methanol and soaked for 15 min in transfer buffer, was placed on the gel. The gel and PVDF membrane were sandwiched between four pieces of Whatman 3MM paper and placed into a Transphor electrophoresis unit (Hoefer Scientific Instruments). Electrotransfer was performed at 70 volts for 45-60 min at ambient temperature. The PVDF membrane was briefly 3 Initial 125 I was 2 mCi. rinsed in water and then stained in 0.025% (w/v) Coomassie Blue R-250 in 40% methanol for 5 min. Excess stain was removed with 45% methanol, 10% acetic acid (aldehyde-free) for 10 min. The blot was allowed to dry for 30 min before autoradiography. Radiolabeled peptides identified by autoradiography were excised from the PVDF membrane using a clean razor blade and sent to the Michigan State University Macromolecular Structure Facility for NH 2 -terminal microsequencing. Automated sequence determinations were confirmed by manually reading the HPLC chromatograms.
Cyanogen Bromide Cleavage of [ 125 I]TBZ-AIPP-labeled rVMAT2-Purified rVMAT2 (250 g in 1 ml of I 3 -0.08% digitonin and 250 mM ␣-mm) was photoaffinity labeled with 2 nM [
125 I]TBZ-AIPP. To the photoaffinity-labeled rVMAT2 was added 125 l of 100 mM NaHCO 3 , pH 7.8, and 50 g of trypsin. The sample was incubated at 37°C for 3 h after which time SDS-PAGE loading buffer was added. Peptides were resolved on a 12% SDS-polyacrylamide gel. An overnight autoradiogram of the "wet" gel at Ϫ80°C was obtained (the gel was not chemically fixed, stained, or destained). The autoradiogram was used as a template to excise the portion of the gel containing the radiolabeled 38-kDa peptide with a razor blade. The gel slices were placed into a 15-ml conical centrifuge tube and minced with a metal spatula. Water was added to form a slurry. The tube was mixed by tumbling overnight at 4°C. The gel slurry was centrifuged at 1,600 ϫ g for 5 min, and the supernatant was saved. Water was again added to the gel pieces, and this was tumbled for an additional 2 h at 4°C. The gel slurry was transferred to a Bio-Spin spin-column (Bio-Rad), and the water was collected by centrifugation at 1,600 ϫ g for 5 min. Radioactivity in the water elution and remaining in the gel was quantitated using a Packard ␥-counter. Typical yield from such a procedure was Ͼ75% eluted. The eluted material was concentrated by lyophilization. The sample was resuspended in 100 l of 0.1 N HCl, and CNBr was added to 0.2 M (from a 5 M stock solution in acetonitrile). The cleavage reaction was incubated for 15 h at ambient temperature (34) .
Purification of [ 125 I]TBZ-AIPP-labeled CNBr
Peptides-Low molecular weight peptides were resolved with 16.5:6% Tricine SDS-polyacrylamide gels, according to the procedure of Schä gger and von Jagow (31) . Precautions were taken to prevent NH 2 -terminal blocking of the peptides, as described previously. Following electrophoresis of the peptides, the SDS-polyacrylamide gel was electrotransferred to a PVDF membrane as described previously.
Automated Edman Degradation-Amino-terminal amino acid sequence analysis was performed by Dr. Joe Leykam of the Michigan State University Macromolecular Structure Facility using automated Edman degradation in an Applied Biosystem 477A gas phase amino acid sequencer. Phenylthiohydantoin amino acid derivatives were identified by HPLC.
SDS-PAGE Analysis-Proteins and peptides were analyzed according to the method of Laemmli (35) using either 12% or 10 -18% gradient polyacrylamide gels using the following proteins as molecular mass markers: myosin (205 kDa), ␤-galactosidase (116 kDa), phosphorylase b (97.4 kDa), bovine serum albumin (66 kDa), ovalbumin (45 kDa), glyceraldehyde-3-phosphate dehydrogenase (36 kDa), carbonic anhydrase (29 kDa), trypsinogen (24 kDa), soybean trypsin inhibitor (20 kDa), ␣-lactalbumin (14.2 kDa), and aprotinin (6.5 kDa). Prestained molecular mass markers were as follows: myosin (213 kDa), ␤-galactosidase (123 kDa), bovine serum albumin (85 kDa), ovalbumin (50.3 kDa), carbonic anhydrase (33.3 kDa), soybean trypsin inhibitor (28.5 kDa), lysozyme (18.9 kDa), and aprotinin (7.8 kDa). Autoradiography was performed with Kodak X-Omat film at Ϫ80°C using a Quanta III (NEN Life Science Products) intensifying screen. The 17-kDa peptide contained the majority of the radiolabel. Photolabeling in the presence of 100 M 7-aminoketanserin showed that all four peptides were specifically labeled (data not shown). The 17-kDa radiolabeled peptide, identified by the arrow, was excised with a razor blade and NH 2 -terminal microsequenced. The sequence obtained and its position in rV-MAT2 are shown in Fig. 3B . The sequence started at the NH 2 terminus of the rVMAT2 sequence and matched through 14 cycles with the predicted amino acids. Only one sequence was obtained, supporting the fact that only one peptide migrated at this position. One amino acid at position 14 was not identified with certainty because of the low yield at this cycle and was assigned as a glutamine. The amino acid as predicted by the cDNA is a tryptophan and was confirmed by sequencing of the cDNA insert.
RESULTS

Substrate Protection of [
To identify the position of [ 125 I]AZIK insertion within the 17-kDa peptide, radiosequencing was performed on this peptide. Release of 125 I was found to occur at the cycle corresponding to lysine 20 of rVMAT2, a nucleophilic amino acid, which would be expected to react with aryl nitrenes. Because the location of the [ 125 I]AZIK insertion site was within the first 25 amino acids from the NH 2 terminus, the label release experiment was repeated using the entire undigested [ peptides by 100 M TBZ was quantitative (Fig. 2) . The photoaffinity-labeled rVMAT2 was then incubated with trypsin for 3 h and the peptides separated on a 10 -18% SDS-polyacrylamide gradient gel. The gel was electrotransferred to a PVDF membrane as described under "Experimental Procedures." Fig. 5A shows an autoradiogram of the PVDF membrane. The radiolabeled peptides indicated by the arrows were excised and NH 2 -terminal microsequenced. Fig. 5B shows the NH 2 -terminal sequences obtained from the peptides and their location on the model of VMAT. The NH 2 terminus of the largest peptide, identified by arrow 1 in Fig. 5A , begins between the third and fourth putative glycosylation sites on the large loop between transmembrane domains 1 and 2. On the basis of its molecular weight, this peptide contains putative TMDs 2-11, with its COOH terminus between TMD11 and TMD12, or in TMD12. (31) . The gel was transferred to a PVDF membrane and an autoradiogram obtained. A very small radiolabeled peptide of less than 2 kDa was observed (Fig. 6A ). This region of the PVDF membrane was excised and NH 2 -terminal sequenced. The NH 2 -terminal sequence determined from this peptide is shown in Fig. 6B , as well as its location in a model of VMAT. DISCUSSION We had reported previously that rVMAT2 expressed in Sf9 cells could be purified in large quantities. 2 (Fig. 2, A and  B) . The concentration of the substrates used in this experiment was 1 mM. Serotonin, the highest affinity substrate of the three, inhibits 
Similar results were obtained for inhibition of [
125 I]TBZ-AIPP photoaffinity labeling by VMAT substrates (Fig. 2, C and D Several proteases were tested for cleavage of the radiolabeled rVMAT2. It was observed that trypsin cleaved both [
I]AZIK-and [
125 I]TBZ-AIPP-labeled rVMAT2 rapidly. Because the rVMAT2 was purified in a mixture of protease inhibitors, it was necessary to use large amounts of trypsin to digest the radiolabeled samples; ratios of trypsin to rVMAT2 as high as 1:2 were used, but a ratio of 1:5 was used regularly. The radiolabeled tryptic peptides from both [ (Fig. 3A) . Trypsin cleavage of [ 125 I]TBZ-AIPP-labeled rVMAT2 resulted in a similar 38-kDa, 17-kDa, and 10-kDa peptide. A fourth peptide of 8 kDa appeared with the concomitant loss of 17-kDa peptide. An interesting observation is that although the 17-kDa peptide from both photoaffinity labels migrated with similar electrophoretic mobility, and both peptides have the same NH 2 -terminal sequence, the peptide resulting from the Fig. 5A ), the same sequence as above was obtained. The same NH 2 -terminal sequence was also obtained when the smaller peptides from [
125 I]TBZ-AIPPlabeled peptides were sequenced (peptides 3 and 4, Fig. 5A ). For each of these peptides, only one peptide was visible on the Coomassie-stained PVDF membrane, and only one sequence was obtained from the sequencer, indicating that these peptides were homogeneous. These data, taken together, indicate that [
125 I]AZIK reacts primarily at the NH 2 terminus of rVMAT2, photoinserting into lysine 20, and [
125 I]TBZ-AIPP inserts partially into this region (see the model presented in Fig. 7) .
The other tryptic peptide generated with both labels is the 38-kDa peptide. [
125 I]TBZ-AIPP primarily labels this peptide, whereas [
125 I]AZIK only labels this peptide slightly. The NH 2 terminus of this peptide begins in the large loop between TMD1 and TMD2 (Fig. 5) , and the molecular weight is consistent with this fragment extending to TMD12. This tryptic fragment derived from [
125 I]TBZ-AIPP-labeled rVMAT2 was purified and further cleaved by CNBr. This cleavage was performed under denaturing conditions (0.1 N HCl), after elution of the 38-kDa peptide from an SDS-polyacrylamide gel slice. Cleavage by CNBr resulted in a small radiolabeled polypeptide of less than 2 kDa (Fig. 6A ). When this peptide was excised from the PVDF membrane and NH 2 -terminal microsequenced, a single sequence was identified as shown in Fig. 6B 125 I]TBZ-AIPP labeled both TMD1 and TMD10/11, these two domains must be close spatially. Therefore, our model, as shown in Fig. 7 , is that TMD1 and TMD10/11 are juxtaposed.
Because [ 125 I]AZIK derivatizes Lys-20 at the NH 2 terminus of rVMAT2, the azide moiety must be positioned within covalent bond-forming distance of this residue. The putative TMDs may form a channel in the vesicle membrane through which the protons and amines pass. Therefore, the putative TMDs in this model are arranged in a fashion that juxtaposes TMD1 with the TMD10/11 region. A recent report by Merickel et al. (30) is consistent with this model. Using site-directed mutagenesis, the authors determined that there is an ion pair formed between Lys-139 and Asp-427 in TMD2 and TMD11, respectively.
The model is also supported by the work performed using chimeric VMAT1/VMAT2 proteins (44) . Replacing TMD1 of VMAT1 with TMD1 of VMAT2 increased the affinity of the transporter for inhibitors and substrates to an intermediate level between VMAT1 and VMAT2. The authors propose the possible interaction of this region with either the ligand or other domains of the transporter. Data from this study suggest that TMD1 interacts with both the ligand (inhibitors and substrates) as well as the TMD10/11 region of the transporter. This hypothesis is supported by the observation that chimeric transporters containing TMD9 -TMD12 of VMAT2 had VMAT2-like binding affinities only in the presence of NH 2 -terminal VMAT2 sequence and a recent report that residues Lys-139 in TMD2 and Asp-427 in TMD 11 form an ion pair. These observations are suggestive of an interaction between the NH 2 and COOH termini of VMAT2. An interesting set of experiments to address the question of NH 2 and COOH termini interaction would be to synthesize a chimeric transporter that contains TMD1 and TMD10 -12 of VMAT2 and the remaining sequence of VMAT1. It would be predicted, based on the model, that this construct would possess properties of VMAT2 (i.e. high affinity for TBZ and substrates).
The multiple insertion sites for [ 125 I]TBZ-AIPP can be explained using the model in Fig. 7B . The iodophenylazide moiety is connected to the TBZ backbone by a long, flexible alkyl chain. If TMD1 and TMD10/11 are juxtaposed, as shown in the model, the azide could derivatize either one of these regions. Nitrene insertion is favored by TMD10/11, perhaps due to a more favorable positioning of reactive amino acid side chains. Determination of the insertion site for [
125 I]AZIK in the 38 kDa tryptic fragment should resolve the proximity hypothesis of TMD1 and TMD10/11.
The data presented in this study indicate that TMD1 and TMD10/11 are juxtaposed and perhaps interacting in a functionally significant manner. Additional experiments are needed to confirm this model, such as the use of ketanserin and TBZ molecules with the photoactive moiety in various positions on the molecule. Of particular interest would be a TBZ derivative in which the azide is positioned in the dopamine analo- gous region. Another photoaffinity label which would provide useful information would be a ketanserin derivative with the photoactive moiety at the opposite end of the ketanserin molecule.
